VL and CD4 at switch to second-line for first-line failure in patients receiving and not receiving CD4 count monitoring.

Development and validation of decision rules to guide frequency of monitoring CD4 cell count in HIV-1 infection before starting antiretroviral therapy

Buclin, Thierry
Telenti, Amalio
Perera, Rafael
Csajka, Chantal
Furrer, Hansjakob
Aronson, Jeffrey K.
Glasziou, Paul P.

January 2011

Background Although CD4 cell count monitoring is used to decide when to start antiretroviral ther...

CD4 cell-monitored treatment interruption in patients with a CD4 cell count > 500 x 106 cells/l

C. Mussini
A. Bedini
V. Borghi
G. Guaraldi
R. Esposito
E. Barchi
R. Enilia
A. Cozzi Lepri
A. N. Philips
P. Ortolani
G. Bratt
L. E. Eriksson
L. Sighinolfi
A. Cossarizza
A. De Luca
S. Di Giambenedetto
A. Antinori
International Study Group on CD4 monitored Treatment Interruptions
A. d'Arminio Monforte

January 2005

BACKGROUND: Little is known about CD4 cell count changes in patients with high CD4 cell counts who i...

Development and Validation of Decision Rules to Guide Frequency of Monitoring CD4 Cell Count in HIV-1 Infection before Starting Antiretroviral Therapy

Thierry Buclin
Amalio Telenti
Rafael Perera
Chantal Csajka
Hansjakob Furrer
Jeffrey K
Paul P. Glasziou

August 2016

Background: Although CD4 cell count monitoring is used to decide when to start antiretroviral therap...

Ability of a single CD4 at switch to second-line for first-line failure to predict VL.

Charles F. Gilks (164480)
A. Sarah Walker (145609)
Paula Munderi (164469)
Cissy Kityo (168842)
Andrew Reid (168831)
Elly Katabira (10701)
Ruth L. Goodall (380311)
Heiner Grosskurth (37057)
Peter Mugyenyi (168847)
James Hakim (164478)
Diana M. Gibb (164420)

February 2013

(a) in patients not receiving routine CD4 count monitoring (CDM: 20% >250 cells/mm3). (b) in pati...

CD4 and VL at switch to second-line for first-line failure in patients receiving 12-weekly CD4 count monitoring, but no VL monitoring (LCM).

Charles F. Gilks (164480)
A. Sarah Walker (145609)
Paula Munderi (164469)
Cissy Kityo (168842)
Andrew Reid (168831)
Elly Katabira (10701)
Ruth L. Goodall (380311)
Heiner Grosskurth (37057)
Peter Mugyenyi (168847)
James Hakim (164478)
Diana M. Gibb (164420)

February 2013

*mostly CD4 declines to just over 100 cells/mm3†65/265 (25%) also had WHO 4 eve...

CD4 and VL at switch to second-line for first-line failure in patients not receiving CD4 or VL count monitoring (CDM).

Charles F. Gilks (164480)
A. Sarah Walker (145609)
Paula Munderi (164469)
Cissy Kityo (168842)
Andrew Reid (168831)
Elly Katabira (10701)
Ruth L. Goodall (380311)
Heiner Grosskurth (37057)
Peter Mugyenyi (168847)
James Hakim (164478)
Diana M. Gibb (164420)

February 2013

*p = 0.84 adjusted for whether whether enrolled in second-line studies (p<0.0001) and whether swi...

Utility of CD4 cell counts for early prediction of virological failure during antiretroviral therapy in a resource-limited setting.

Badri, Motasim
Lawn, Stephen D
Wood, Robin

January 2008

BACKGROUND: Viral load monitoring is not available for the vast majority of patients receiving antir...

A single CD4 test with 250 cells/mm3 threshold predicts viral suppression in HIV-infected adults failing first-line therapy by clinical criteria.

Charles F Gilks
A Sarah Walker
Paula Munderi
Cissy Kityo
Andrew Reid
Elly Katabira
Ruth L Goodall
Heiner Grosskurth
Peter Mugyenyi
James Hakim
Diana M Gibb

In low-income countries, viral load (VL) monitoring of antiretroviral therapy (ART) is rarely availa...

A single CD4 test with 250 cells/mm3 threshold predicts viral suppression in HIV-infected adults failing first-line therapy by clinical criteria

Gilks, C
Walker, A
Munderi, P
Kityo, C
Reid, A
Katabira, E
Goodall, R
Grosskurth, H
Mugyenyi, P
Hakim, J
Gibb, D

January 2013

BACKGROUND: In low-income countries, viral load (VL) monitoring of antiretroviral therapy (ART) is r...

Threshold Predicts Viral Suppression in HIV-Infected Adults Failing First-Line Therapy by Clinical Criteria

Gilks Charles F.
Walker A. Sarah
Munderi Paula
Kityo Cissy
Reid Andrew
Katabira Elly
Goodall Ruth L.
Grosskurth Heiner
Mugyenyi Peter
Hakim James
Gibb Diana M.

February 2013

In low-income countries, viral load (VL) monitoring of antiretroviral therapy (ART) is rarely availa...

Effects of CD4 Monitoring Frequency on Clinical End Points in Clinically Stable HIV-Infected Patients With Viral Suppression

안진영
최준용

January 2015

BACKGROUND: Current treatment guidelines for HIV infection recommend routine CD4 lymphocyte (CD4) co...

Enrollment and follow-up.

Wang Zhou (324766)
Min Zhao (66793)
Xia Wang (36364)
Robert F. Schilling (667457)
Sheng Zhou (66217)
Hong-Yan Qiu (667458)
Nian-Hua Xie (667459)
Man-Qing Liu (324762)
Han-Sheng Dong (667460)
Zhong-Zhao Yao (667461)
Thomas Cai (667462)

December 2014

(Note: a. includes 3 patients whose CD4 cell count is ≦350 cells/µL; b. includes 16 patients whos...

Pattern of CD4 cell count monitoring by follow-up time (N = 1,321).

Kesetebirhan Delele Yirdaw (612063)
Susan Hattingh (737310)

May 2015

The actual number of CD4 cell count tests performed is seen to decline over time even taking into...

Development and validation of decision rules to guide frequency of monitoring CD4 cell count in HIV-1 infection before starting antiretroviral therapy.

Thierry Buclin
Amalio Telenti
Rafael Perera
Chantal Csajka
Hansjakob Furrer
Jeffrey K Aronson
Paul P Glasziou

BACKGROUND: Although CD4 cell count monitoring is used to decide when to start antiretroviral therap...

Single CD4 test with 250 Cells/Mm(3) threshold predicts viral suppression in HIV-infected adults failing first-line therapy by clinical criteria

Gilks, Charles F.
Walker, A. Sarah
Munderi, Paula
Kityo, Cissy
Reid, Andrew
Katabira, Elly
Goodall, Ruth L.
Grosskurth, Heiner
Mugyenyi, Peter
Hakim, James
Gibb, Diana M.

February 2013

Background: In low-income countries, viral load (VL) monitoring of antiretroviral therapy (ART) is r...

Development and validation of decision rules to guide frequency of monitoring CD4 cell count in HIV-1 infection before starting antiretroviral therapy

Buclin, Thierry
Telenti, Amalio
Perera, Rafael
Csajka, Chantal
Furrer, Hansjakob
Aronson, Jeffrey K.
Glasziou, Paul P.

January 2011

Background Although CD4 cell count monitoring is used to decide when to start antiretroviral ther...

CD4 cell-monitored treatment interruption in patients with a CD4 cell count > 500 x 106 cells/l

C. Mussini
A. Bedini
V. Borghi
G. Guaraldi
R. Esposito
E. Barchi
R. Enilia
A. Cozzi Lepri
A. N. Philips
P. Ortolani
G. Bratt
L. E. Eriksson
L. Sighinolfi
A. Cossarizza
A. De Luca
S. Di Giambenedetto
A. Antinori
International Study Group on CD4 monitored Treatment Interruptions
A. d'Arminio Monforte

January 2005

BACKGROUND: Little is known about CD4 cell count changes in patients with high CD4 cell counts who i...

Development and Validation of Decision Rules to Guide Frequency of Monitoring CD4 Cell Count in HIV-1 Infection before Starting Antiretroviral Therapy

Thierry Buclin
Amalio Telenti
Rafael Perera
Chantal Csajka
Hansjakob Furrer
Jeffrey K
Paul P. Glasziou

August 2016

Background: Although CD4 cell count monitoring is used to decide when to start antiretroviral therap...

Ability of a single CD4 at switch to second-line for first-line failure to predict VL.

Charles F. Gilks (164480)
A. Sarah Walker (145609)
Paula Munderi (164469)
Cissy Kityo (168842)
Andrew Reid (168831)
Elly Katabira (10701)
Ruth L. Goodall (380311)
Heiner Grosskurth (37057)
Peter Mugyenyi (168847)
James Hakim (164478)
Diana M. Gibb (164420)

February 2013

(a) in patients not receiving routine CD4 count monitoring (CDM: 20% >250 cells/mm3). (b) in pati...

CD4 and VL at switch to second-line for first-line failure in patients receiving 12-weekly CD4 count monitoring, but no VL monitoring (LCM).

Charles F. Gilks (164480)
A. Sarah Walker (145609)
Paula Munderi (164469)
Cissy Kityo (168842)
Andrew Reid (168831)
Elly Katabira (10701)
Ruth L. Goodall (380311)
Heiner Grosskurth (37057)
Peter Mugyenyi (168847)
James Hakim (164478)
Diana M. Gibb (164420)

February 2013

*mostly CD4 declines to just over 100 cells/mm3†65/265 (25%) also had WHO 4 eve...

CD4 and VL at switch to second-line for first-line failure in patients not receiving CD4 or VL count monitoring (CDM).

Charles F. Gilks (164480)
A. Sarah Walker (145609)
Paula Munderi (164469)
Cissy Kityo (168842)
Andrew Reid (168831)
Elly Katabira (10701)
Ruth L. Goodall (380311)
Heiner Grosskurth (37057)
Peter Mugyenyi (168847)
James Hakim (164478)
Diana M. Gibb (164420)

February 2013

*p = 0.84 adjusted for whether whether enrolled in second-line studies (p<0.0001) and whether swi...

Utility of CD4 cell counts for early prediction of virological failure during antiretroviral therapy in a resource-limited setting.

Badri, Motasim
Lawn, Stephen D
Wood, Robin

January 2008

BACKGROUND: Viral load monitoring is not available for the vast majority of patients receiving antir...

A single CD4 test with 250 cells/mm3 threshold predicts viral suppression in HIV-infected adults failing first-line therapy by clinical criteria.

Charles F Gilks
A Sarah Walker
Paula Munderi
Cissy Kityo
Andrew Reid
Elly Katabira
Ruth L Goodall
Heiner Grosskurth
Peter Mugyenyi
James Hakim
Diana M Gibb

In low-income countries, viral load (VL) monitoring of antiretroviral therapy (ART) is rarely availa...

A single CD4 test with 250 cells/mm3 threshold predicts viral suppression in HIV-infected adults failing first-line therapy by clinical criteria

Gilks, C
Walker, A
Munderi, P
Kityo, C
Reid, A
Katabira, E
Goodall, R
Grosskurth, H
Mugyenyi, P
Hakim, J
Gibb, D

January 2013

BACKGROUND: In low-income countries, viral load (VL) monitoring of antiretroviral therapy (ART) is r...

Threshold Predicts Viral Suppression in HIV-Infected Adults Failing First-Line Therapy by Clinical Criteria

Gilks Charles F.
Walker A. Sarah
Munderi Paula
Kityo Cissy
Reid Andrew
Katabira Elly
Goodall Ruth L.
Grosskurth Heiner
Mugyenyi Peter
Hakim James
Gibb Diana M.

February 2013

In low-income countries, viral load (VL) monitoring of antiretroviral therapy (ART) is rarely availa...

Effects of CD4 Monitoring Frequency on Clinical End Points in Clinically Stable HIV-Infected Patients With Viral Suppression

안진영
최준용

January 2015

BACKGROUND: Current treatment guidelines for HIV infection recommend routine CD4 lymphocyte (CD4) co...

Enrollment and follow-up.

Wang Zhou (324766)
Min Zhao (66793)
Xia Wang (36364)
Robert F. Schilling (667457)
Sheng Zhou (66217)
Hong-Yan Qiu (667458)
Nian-Hua Xie (667459)
Man-Qing Liu (324762)
Han-Sheng Dong (667460)
Zhong-Zhao Yao (667461)
Thomas Cai (667462)

December 2014

(Note: a. includes 3 patients whose CD4 cell count is ≦350 cells/µL; b. includes 16 patients whos...

Pattern of CD4 cell count monitoring by follow-up time (N = 1,321).

Kesetebirhan Delele Yirdaw (612063)
Susan Hattingh (737310)

May 2015

The actual number of CD4 cell count tests performed is seen to decline over time even taking into...

Development and validation of decision rules to guide frequency of monitoring CD4 cell count in HIV-1 infection before starting antiretroviral therapy.

Thierry Buclin
Amalio Telenti
Rafael Perera
Chantal Csajka
Hansjakob Furrer
Jeffrey K Aronson
Paul P Glasziou

BACKGROUND: Although CD4 cell count monitoring is used to decide when to start antiretroviral therap...

Single CD4 test with 250 Cells/Mm(3) threshold predicts viral suppression in HIV-infected adults failing first-line therapy by clinical criteria

Gilks, Charles F.
Walker, A. Sarah
Munderi, Paula
Kityo, Cissy
Reid, Andrew
Katabira, Elly
Goodall, Ruth L.
Grosskurth, Heiner
Mugyenyi, Peter
Hakim, James
Gibb, Diana M.

February 2013

Background: In low-income countries, viral load (VL) monitoring of antiretroviral therapy (ART) is r...

Development and validation of decision rules to guide frequency of monitoring CD4 cell count in HIV-1 infection before starting antiretroviral therapy

Buclin, Thierry
Telenti, Amalio
Perera, Rafael
Csajka, Chantal
Furrer, Hansjakob
Aronson, Jeffrey K.
Glasziou, Paul P.

January 2011

Background Although CD4 cell count monitoring is used to decide when to start antiretroviral ther...

CD4 cell-monitored treatment interruption in patients with a CD4 cell count > 500 x 106 cells/l

C. Mussini
A. Bedini
V. Borghi
G. Guaraldi
R. Esposito
E. Barchi
R. Enilia
A. Cozzi Lepri
A. N. Philips
P. Ortolani
G. Bratt
L. E. Eriksson
L. Sighinolfi
A. Cossarizza
A. De Luca
S. Di Giambenedetto
A. Antinori
International Study Group on CD4 monitored Treatment Interruptions
A. d'Arminio Monforte

January 2005

BACKGROUND: Little is known about CD4 cell count changes in patients with high CD4 cell counts who i...

Development and Validation of Decision Rules to Guide Frequency of Monitoring CD4 Cell Count in HIV-1 Infection before Starting Antiretroviral Therapy

Thierry Buclin
Amalio Telenti
Rafael Perera
Chantal Csajka
Hansjakob Furrer
Jeffrey K
Paul P. Glasziou

August 2016

Background: Although CD4 cell count monitoring is used to decide when to start antiretroviral therap...

VL and CD4 at switch to second-line for first-line failure in patients receiving and not receiving CD4 count monitoring.

Abstract

Extracted data

VL and CD4 at switch to second-line for first-line failure in patients receiving and not receiving CD4 count monitoring.

Abstract

Extracted data

Related items

Related items